Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4331852 | 0.83 | NPC1 (0.55) | NPC1ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL11241976 | 0.83 | CHRNB2 (0.56) | NPC1ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL655407 | 0.82 | KMT2A (0.62) | NPC1ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL6982170 | 0.81 | MAPT (0.51) | NPC1ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL6482501 | 0.79 | TSHR (0.57) | NPC1ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL6482493 | 0.79 | TSHR (0.57) | NPC1ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL28162666 | 0.79 | MAPT (0.56) | ALDH1A1MAPTLMNA | |
| SCHEMBL11661596 | 0.79 | NPC1 (0.43) | NPC1ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL773149 | 0.78 | NPC1 (0.53) | NPC1ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL7432296 | 0.78 | KMT2A (0.52) | NPC1ALDH1A1MAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1133484-A2 | HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS | AstraZeneca AB (SE) | 2001-09-19 | — | — | EP | disclosed |
| WO-2000005223-A2 | HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS | ASTRAZENECA AB (SE) | 2000-02-03 | — | — | WO | disclosed |